Transaction Details

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.15 to $88.14, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) of this Form 4. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $89.14, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.15 to $89.28, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.17 to $86.16, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.22 to $87.21, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.22 to $88.20, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.67 to $89.12, inclusive. | The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. | The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.